CIK: 1242615 - Address: 177 E Colorado Blvd, Ste 700, Pasadena, CA 91105
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/30/24 17:12
12/27/24
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YCADS-5720.000-3-737D
3/6/23 18:04
3/3/23
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YCADS-37132.650-11-598D
1/4/22 21:33
1/3/22
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YCADS-26264.750-4-455D
9/14/21 17:25
9/13/21
ARWRArrowhead Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YCADS-31963.760-5-369D
8/17/20 09:04
8/13/20
TNXPTonix Pharmaceuticals Holding Corp.NVHealthDrugPharmaceutical PreparationsOlukotun Adeoye YNYDP50.940005New5D
9/6/11 17:43
9/2/11
ICGNIcagen IncDEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YNCDM.d143.20053318D
2/9/04 21:38
2/5/04
ESPREsperion Therapeutics Inc/miDEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YMIOSVP ClinM.d10016.24060D
1/20/04 10:46
1/16/04
ESPREsperion Therapeutics Inc/miDEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YMIOSVP ClinS-80434.650-23-1000D
1/20/04 10:46
1/16/04
ESPREsperion Therapeutics Inc/miDEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YMIOSVP ClinM32516.240200D
12/30/03 19:02
11/18/03
ESPREsperion Therapeutics Inc/miDEHealthDrugPharmaceutical PreparationsOlukotun Adeoye YMIOSVP ClinM185.5203New3D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact